ArticleGut and liver2021

Comparison of Clinical Outcomes of Borderline Resectable Pancreatic Cancer According to the Neoadjuvant Chemo-Regimens: Gemcitabine versus FOLFIRINOX.

Yoo Jin Choi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.